Dara Biosciences, Inc. Asset Turnover Ratio (DARA), as of third quarter 2015, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Dara Biosciences, Inc.  (DARA)
 

Dara Biosciences Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Dara Biosciences, Inc. asset turnover ratio, the ability of Dara Biosciences, Inc.'s assets to generate revenue in the third quarter 2015, increased sequentially to 0.25 in the third quarter (Sep 30 2015), yet the ratio remained below the average, as DARA's position remain challenging.

Within sector 87 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2015 compared to the preceding quarter from to 3083.

Asset Turnover Ratio Definition



DARA Asset Turnover Ratio (Sep 30 2015)
III. Quarter
(Jun 30 2015)
II. Quarter
(Mar 31 2015)
I. Quarter
(Sep 30 2014)
III. Quarter
(Jun 30 2014)
II. Quarter
Y / Y Asset Change -47.75 % -41.59 % 28.98 % 132.23 % 151.54 %
Y / Y Revenue Change 188.5 % 513.5 % 257.72 % 330.42 % 432.13 %
Asset Turnover Ratio (TTM) 0.25 0.17 0.1 0.08 0.06
DARA's Total Ranking # 3083 # # # #
Seq. Asset Change -18.47 % -19.52 % -20.45 % 0.1 % -8.86 %
Seq. Revenue Change 19.21 % 51.92 % 9.1 % 46.02 % 153.5 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 88
Healthcare Sector # 277
Overall Market # 3083

Asset Turnover Ratio Statistics
High Average Low
2.71 2.29 1.88
(Dec 31 2013)   (Sep 30 2013)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2015, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2015 Assets at quarter ending Sep 30 2015
3m Company  0.97 $ 30,695.000  Millions$ 31,639.500  Millions
Inotiv Inc   0.97 $ 22.698  Millions$ 23.484  Millions
Cantel Medical Corp   0.97 $ 581.972  Millions$ 602.319  Millions
Misonix Inc   0.96 $ 22.916  Millions$ 23.795  Millions
Lumos Pharma Inc   0.95 $ 230.094  Millions$ 241.814  Millions
Camp4 Therapeutics Corporation  0.94 $ 267.652  Millions$ 283.350  Millions
Cutera Inc   0.94 $ 90.218  Millions$ 95.775  Millions
Sonoma Pharmaceuticals Inc   0.94 $ 14.932  Millions$ 15.907  Millions
Luna Innovations Inc  0.94 $ 34.760  Millions$ 37.124  Millions
Myriad Genetics Inc   0.94 $ 737.763  Millions$ 789.016  Millions
Anixa Biosciences Inc   0.93 $ 9.255  Millions$ 9.951  Millions
Lemaitre Vascular Inc   0.93 $ 76.550  Millions$ 82.729  Millions
Gadsden Properties, Inc.  0.92 $ 97.473  Millions$ 105.945  Millions
Veru Inc   0.92 $ 32.605  Millions$ 35.551  Millions
Shattuck Labs Inc   0.91 $ 0.931  Millions$ 1.020  Millions
Apyx Medical Corp  0.91 $ 28.691  Millions$ 31.668  Millions
Bruker Corporation  0.91 $ 1,653.600  Millions$ 1,825.200  Millions
Supernus Pharmaceuticals inc   0.90 $ 135.013  Millions$ 149.489  Millions
Fonar Corporation  0.90 $ 68.677  Millions$ 76.433  Millions
Atrion Corporation  0.89 $ 146.053  Millions$ 163.279  Millions
Xtant Medical Holdings Inc   0.89 $ 46.170  Millions$ 51.984  Millions
Biolase Inc   0.89 $ 47.196  Millions$ 53.147  Millions
Semler Scientific inc   0.89 $ 5.122  Millions$ 5.775  Millions
Carlisle Companies Incorporated  0.89 $ 3,457.000  Millions$ 3,899.675  Millions
Steris Plc  0.88 $ 1,904.690  Millions$ 2,154.447  Millions
Select Medical Holdings Corp  0.88 $ 3,212.085  Millions$ 3,641.900  Millions
Axogen inc   0.88 $ 24.316  Millions$ 27.718  Millions
Msa Safety Inc  0.87 $ 1,129.819  Millions$ 1,296.631  Millions
Adaptive Biotechnologies Corporation  0.87 $ 329.328  Millions$ 379.873  Millions
Lannett Company Inc  0.87 $ 419.883  Millions$ 484.644  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.